Parametric Portfolio Associates LLC Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Parametric Portfolio Associates LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 2,542 shares of the exchange traded fund’s stock, valued at approximately $223,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Main Management ETF Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 6.4% during the 2nd quarter. Main Management ETF Advisors LLC now owns 299,700 shares of the exchange traded fund’s stock worth $26,287,000 after purchasing an additional 18,000 shares in the last quarter. LPL Financial LLC grew its holdings in shares of SPDR S&P Biotech ETF by 1.0% in the 2nd quarter. LPL Financial LLC now owns 219,154 shares of the exchange traded fund’s stock valued at $19,222,000 after acquiring an additional 2,096 shares in the last quarter. Whittier Trust Co. grew its holdings in shares of SPDR S&P Biotech ETF by 3.6% in the 2nd quarter. Whittier Trust Co. now owns 200,588 shares of the exchange traded fund’s stock valued at $17,593,000 after acquiring an additional 7,012 shares in the last quarter. Weatherly Asset Management L. P. grew its holdings in shares of SPDR S&P Biotech ETF by 2.4% in the 2nd quarter. Weatherly Asset Management L. P. now owns 159,024 shares of the exchange traded fund’s stock valued at $13,948,000 after acquiring an additional 3,772 shares in the last quarter. Finally, Main Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 0.5% in the 2nd quarter. Main Management LLC now owns 157,918 shares of the exchange traded fund’s stock valued at $13,851,000 after acquiring an additional 845 shares in the last quarter.

Shares of NYSEARCA XBI traded up $2.03 during mid-day trading on Friday, hitting $83.96. The company had a trading volume of 5,229,384 shares, compared to its average volume of 4,687,412. The firm has a 50-day simple moving average of $79.49 and a two-hundred day simple moving average of $82.67. SPDR S&P Biotech ETF has a one year low of $64.38 and a one year high of $93.87.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Story: If I purchase shares through a brokerage account, am I the holder of record?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News